登录 | 注册    关注公众号  
微信公众号
搜索
 > 【Apolipoprotein E】

Apolipoprotein E信息

英文名称:Apolipoprotein E
中文名称:载脂蛋白E
靶点别称:APOE,Apolipoprotein E,Alzheimer Disease 2 (APOE*E4-Associated, Late Onset),Apolipoprotein E3,LDLCQ5,ApoE4,Apo-E,LPG,AD2,Apolipoproteins E
上市药物数量:0
临床药物数量:2
最高研发阶段:临床二期

Apolipoprotein E产品列表

ACRO质量管理体系
 
评论(3)
APE-H52H6|Human Apolipoprotein E / APOE2 Protein, His Tag (SPR verified)
  1. 181XXXXXXX6
  2. 6人赞
  3. 我们购买这款蛋白用于筛选抗体,主要用于ELISA实验,蛋白活性很好,取得了很好的实验数据,是实验人员的首选蛋白。
  4. 2023-06-02
APE-H52H6|Human Apolipoprotein E / APOE2 Protein, His Tag (SPR verified)
  1. 151XXXXXXX5
  2. 6人赞
  3. 我们主要用于我们筛选出来的优选克隆上,bingding实验以及blocking实验,实验效果很好,因为涉及保密工作图就不放了
  4. 2022-12-09
APE-H5246|Human Apolipoprotein E / APOE3 Protein, His Tag
  1. 159XXXXXXX6
  2. 2人赞
  3. ACRO的ApoE3是我们实验室一直采购的 对比了近岸和自己表达的ApoE3 只有ACRO的活性最好 对于报告细胞株的激活效果最强 因此给我们留下更大的实验窗口 赞赞
  4. >
  5. 2023-12-22
 

Apolipoprotein E分子别名

Apolipoprotein E,APOE,Apo-E

Apolipoprotein E分子背景

APOE is an apolipoprotein, a protein associating with lipid particles, that mainly functions in lipoprotein-mediated lipid transport between organs via the plasma and interstitial fluids. APOE is a core component of plasma lipoproteins and is involved in their production, conversion and clearance. Apoliproteins are amphipathic molecules that interact both with lipids of the lipoprotein particle core and the aqueous environment of the plasma. As such, APOE associates with chylomicrons, chylomicron remnants, very low density lipoproteins (VLDL) and intermediate density lipoproteins (IDL) but shows a preferential binding to high-density lipoproteins (HDL). It also binds a wide range of cellular receptors including the LDL receptor/LDLR, the LDL receptor-related proteins LRP1, LRP2 and LRP8 and the very low-density lipoprotein receptor/VLDLR that mediate the cellular uptake of the APOE-containing lipoprotein particles.

Apolipoprotein E临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验
CN-105 CN-105 临床二期 Aegiscn Llc 脑出血, 中风 详情
LX-1001 LX-1001 临床二期 LEXEO Therapeutics 阿尔茨海默病 详情

消息提示

请输入您的联系方式,再点击提交!

确定